Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOPRAZOLAM vs LORLATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOPRAZOLAM vs LORLATINIB: Safety Overview

Metric LOPRAZOLAM LORLATINIB
Total FAERS Reports 331 5,508
Deaths Reported 36 1,542
Death Rate 10.9% 28.0%
Hospitalizations 183 1,232
Average Patient Age 53.0 yrs 56.5 yrs
% Female Patients 58.8% 54.0%
FDA Approval Date N/A Nov 2, 2018
Manufacturer N/A Pfizer Laboratories Div Pfizer Inc
Route N/A ORAL
Marketing Status N/A Prescription